Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12606779 | Active agent-containing articles | 🖼🧊📄§ | 2026-04-21 | 2043-08-28 | 0 | 31 |
| 12605710 | Flow channel structure for removing foreign substance, method for removing foreign substance, and method for manufacturing lipid particles | 🖼🧊📄§ | 2026-04-21 | 2043-03-13 | 0 | 31 |
| 12605441 | Immunogenic trimers | 🖼🧊📄§ | 2026-04-21 | 2044-06-04 | 0 | 31 |
| 12605452 | Compounds that degrade kinases and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-03 | 0 | 31 |
| 12606875 | Fish Totivirus | 🖼🧊📄§ | 2026-04-21 | 2040-02-04 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605331 | Composition comprising iris-derived exosome as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2043-12-27 | 0 | 31 |
| 12605334 | Method of enhancing the efficacy and stability of ingredients in suspensions | 🖼🧊📄§ | 2026-04-21 | 2043-12-04 | 0 | 31 |
| 12605402 | Therapeutic uses of oxidizing hypotonic acid solutions | 🖼🧊📄§ | 2026-04-21 | 2040-07-02 | 0 | 31 |
| 12606709 | Method for increasing specific surface area of titanium phosphate plate-shaped particles, and powder containing plate-shaped particles derived from titanium phosphate | 🖼🧊📄§ | 2026-04-21 | 2040-05-15 | 0 | 31 |
| 12605239 | Enhancement of hydration and improvement in gut health through cloacal delivery of products | 🖼🧊📄§ | 2026-04-21 | 2041-07-29 | 0 | 31 |
| 12605365 | Losartan liquid formulations and methods of use | 🖼🧊📄§ | 2026-04-21 | 2042-12-05 | 0 | 31 |
| 12605366 | Telmisartan for the treatment of hypertension in dogs | 🖼🧊📄§ | 2026-04-21 | 2040-04-30 | 0 | 31 |
| 12605446 | PSMA-targeted immunotherapies for cancers | 🖼🧊📄§ | 2026-04-21 | 2041-08-20 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |
| 12605414 | Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12605332 | Transdermal delivery formulations | 🖼🧊📄§ | 2026-04-21 | 2042-10-31 | 0 | 31 |
| 12606796 | Delivery of oncolytic viruses using dendritic cells | 🖼🧊📄§ | 2026-04-21 | 2040-05-07 | 0 | 31 |
| 12605343 | Method for producing microbubble-containing electrolyte solution and method for producing microbubble-containing solvent used for preparing microbubble-containing electrolyte solution | 🖼🧊📄§ | 2026-04-21 | 2040-08-24 | 0 | 31 |
| 12605411 | Phospholipid compositions for delivery of therapeutic compounds | 🖼🧊📄§ | 2026-04-21 | 2044-06-05 | 0 | 31 |
| 12605415 | Compositions and methods | 🖼🧊📄§ | 2026-04-21 | 2043-07-11 | 0 | 31 |
| 12605412 | Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments | 🖼🧊📄§ | 2026-04-21 | 2040-09-29 | 0 | 31 |
| 12605355 | HA-paclitaxel conjugate for treatment of mesothelioma | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606528 | Methods and materials for inhibiting NF-kB activity | 🖼🧊📄§ | 2026-04-21 | 2040-11-20 | 0 | 31 |
| 12605448 | Porous self-healing polymer matrix for encapsulation of active macromolecules and methods | 🖼🧊📄§ | 2026-04-21 | 2040-07-20 | 0 | 31 |
| 12605449 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | 🖼🧊📄§ | 2026-04-21 | 2041-07-01 | 0 | 31 |
| 12605472 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-09-17 | 0 | 31 |
| 12605471 | Cromolyn derivatives and related methods of imaging and treatment | 🖼🧊📄§ | 2026-04-21 | 2043-06-02 | 0 | 31 |
| 12605470 | Nanodroplet with layer-by-layer assembly | 🖼🧊📄§ | 2026-04-21 | 2040-11-20 | 0 | 31 |
| 12605473 | Methods for making radiolabeled anti-MET binding proteins | 🖼🧊📄§ | 2026-04-21 | 2043-12-29 | 0 | 31 |
| 12605465 | AAV-NAGLU vectors for treatment of mucopolysaccharidosis IIIB | 🖼🧊📄§ | 2026-04-21 | 2041-03-22 | 0 | 31 |
| 12605464 | Cyclohexane lipidoids for nucleic acid transfection and use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-07-15 | 0 | 31 |
| 12605468 | Oxazine-based fluorophore compounds for nerve-specific imaging | 🖼🧊📄§ | 2026-04-21 | 2041-01-22 | 0 | 31 |
| 12605461 | Hydrogel compositions and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-07-03 | 0 | 31 |
| 12605463 | Tolerogenic artificial antigen-presenting cells | 🖼🧊📄§ | 2026-04-21 | 2040-06-12 | 0 | 31 |
| 12605455 | CAR peptide for improved coronavirus survival | 🖼🧊📄§ | 2026-04-21 | 2041-03-19 | 0 | 31 |
| 12605451 | Targeted plasma protein degradation | 🖼🧊📄§ | 2026-04-21 | 2041-02-04 | 0 | 31 |
| 12605456 | Composition and method for HIP1-targeting inhibitor compounds | 🖼🧊📄§ | 2026-04-21 | 2042-05-28 | 0 | 31 |
| 12605436 | Chikungunya vaccine formulations | 🖼🧊📄§ | 2026-04-21 | 2040-08-10 | 0 | 31 |
| 12605442 | Production of vaccines comprising inactivated SARS-CoV-2 viral particles | 🖼🧊📄§ | 2026-04-21 | 2041-03-05 | 0 | 31 |
| 12605439 | Universal influenza vaccine compositions | 🖼🧊📄§ | 2026-04-21 | 2041-12-28 | 0 | 31 |
| 12605437 | Single shot Chikungunya virus vaccine | 🖼🧊📄§ | 2026-04-21 | 2040-08-10 | 0 | 31 |
| 12605429 | Proteins having pneumococcal capsule degrading activity and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12605457 | Modified EGFR antibody with reduced affinity, drug conjugate, and use thereof | 🖼🧊📄§ | 2026-04-21 | 2041-11-19 | 0 | 31 |
| 12605433 | Antibody specifically binding to PTK7 and use thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-16 | 0 | 31 |
| 12605311 | Hydrogel structure | 🖼🧊📄§ | 2026-04-21 | 2041-02-05 | 0 | 31 |
| 12605310 | Non-aqueous dispersion, preparation method therefor, and cosmetic composition comprising same | 🖼🧊📄§ | 2026-04-21 | 2039-10-08 | 0 | 31 |
| 12605308 | Topical skin care formulations comprising plant extracts | 🖼🧊📄§ | 2026-04-21 | 2043-10-18 | 0 | 31 |
| 12605309 | Pressed powder product and method for preparing the same | 🖼🧊📄§ | 2026-04-21 | 2043-05-25 | 0 | 31 |